NR3C2 and atrial fibrillation: There were also notable differences in medical therapy, particularly in use of antiplatelet therapy (69% of patients without AF vs. 39% of those with AF) and anticoagulant treatment (6% vs. 57%, respectively), but also in relation to diuretics, mineralocorticoid receptor antagonists, antiarrhythmic agents, and digoxin.